Ts-Ting Lin

Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

C. Lai, Yunching Chen, Dong-Yu Gao, 2018, Theranostics.

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.

Yunching Chen, Dong-Yu Gao, D. Wan, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors

R. Jain, K. Flaherty, C. Benes, 2017, Scientific Reports.

CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.

Yunching Chen, Dong-Yu Gao, W. Chiang, 2015, Biomaterials.

CXCR 4-Targeted Lipid-Coated PLGA Nanoparticles Deliver Sorafenib and Overcome

Yunching Chen, Dong-Yu Gao, W. Chiang, 2015 .

Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.

Yunching Chen, Dong-Yu Gao, Jia-yu Liu, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.